{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:49:49Z","timestamp":1782236989596,"version":"3.54.5"},"reference-count":27,"publisher":"BMJ","funder":[{"DOI":"10.13039\/100012155","name":"Channel 7 Telethon Trust","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2026,6,3]]},"DOI":"10.1136\/ejhpharm-2026-004996","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:20:50Z","timestamp":1782235250000},"page":"ejhpharm-2026-004996","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Chemical and visual compatibility of fluconazole injection with parenteral medications used in neonatal intensive care settings"],"prefix":"10.1136","author":[{"given":"D Thisuri N","family":"De Silva","sequence":"first","affiliation":[{"name":"Curtin Medical School, Curtin University, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Curtin Medical School, Curtin University, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Strunk","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre for Vaccines and Infectious Diseases, The University of Western Australia, Perth, Western Australia, Australia"},{"name":"Neonatology, King Edward Memorial Hospital for Women Perth, Subiaco, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeelah","family":"Mukadam","sequence":"additional","affiliation":[{"name":"Pharmacy Department, King Edward Memorial Hospital for Women Perth, Subiaco, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Petrovski","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3850-1778","authenticated-orcid":false,"given":"Kevin T","family":"Batty","sequence":"additional","affiliation":[{"name":"Curtin Medical School, Curtin University, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"2026062310202180000_ejhpharm-2026-004996v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00749-7"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.2","first-page":"45","article-title":"Updated perspectives on the diagnosis and management of neonatal invasive candidiasis","volume":"13","author":"Daniel","year":"2023","journal-title":"Res Rep Neonatol"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.4","unstructured":"ASHP injectable drug information: a comprehensive guide to compatibility and stability. Bethesda (MD) American Society of Health-System Pharmacists; 2025."},{"key":"2026062310202180000_ejhpharm-2026-004996v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304887"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.6","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.174268"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.7","first-page":"744","article-title":"Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration","volume":"48","author":"Lor","year":"1991","journal-title":"Am J Hosp Pharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.8","first-page":"1206","article-title":"Stability of fluconazole in commonly used intravenous antibiotic solutions","volume":"50","author":"Inagaki","year":"1993","journal-title":"Am J Hosp Pharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.9","first-page":"2290","article-title":"Visual compatibility of fluconazole with drugs given by continuous infusion","volume":"51","author":"Ishisaka","year":"1994","journal-title":"Am J Hosp Pharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.10","first-page":"1186","article-title":"Stability of fluconazole in injectable solutions","volume":"50","author":"Hunt-Fugate","year":"1993","journal-title":"Am J Hosp Pharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.11","first-page":"1459","article-title":"Stability of fluconazole and amino acids in parenteral nutrient solutions","volume":"49","author":"Couch","year":"1992","journal-title":"Am J Hosp Pharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.12","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2018-001562"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/jphp.12647","article-title":"Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents","volume":"69","author":"Staven","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.14","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb03159.x"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.15","first-page":"703","article-title":"Stability and compatibility of fluconazole and aminophylline in intravenous admixtures","volume":"50","author":"Johnson","year":"1993","journal-title":"Am J Hosp Pharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.16","unstructured":"European Medicines Agency . ICH Q2(R2) guideline on validation of analytical procedures EMA\/CHMP\/ICH\/82072\/2006. 2023."},{"key":"2026062310202180000_ejhpharm-2026-004996v1.17","first-page":"939","article-title":"Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets","volume":"34","author":"Allen","year":"1977","journal-title":"Am J Hosp Pharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.18","first-page":"2359","article-title":"Physical compatibility of melphalan with selected drugs during simulated Y-site administration","volume":"50","author":"Trissel","year":"1993","journal-title":"Am J Hosp Pharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.19","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16030419","article-title":"The Physicochemical Compatibility of Sildenafil Injection with Parenteral Medications Used in Neonatal Intensive Care Settings","volume":"16","author":"De Silva","year":"2024","journal-title":"Pharmaceutics"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.20","doi-asserted-by":"crossref","first-page":"104043","DOI":"10.1016\/j.xphs.2025.104043","article-title":"Physicochemical compatibility of alprostadil injection with parenteral medications used in neonatal intensive care settings","volume":"115","author":"Hamilton","year":"2026","journal-title":"J Pharm Sci"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00228-024-03678-6","article-title":"Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings","volume":"80","author":"De Silva","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.22","unstructured":"United States Pharmacopeia and National Formulary . USP-NF 2025 ed. Rockville (MD) United States Pharmacopeial Convention; 2025."},{"key":"2026062310202180000_ejhpharm-2026-004996v1.23","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp150853"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.24","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2012-000239"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.25","unstructured":"O\u2019Donnell PB , Bokser AD . Stability of pharmaceutical products . In: Gerbino PP , ed. Remington: the science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2006: 1025\u201336."},{"key":"2026062310202180000_ejhpharm-2026-004996v1.26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejpb.2020.04.008","article-title":"Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - a compatibility study","volume":"151","author":"AlSalman","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"2026062310202180000_ejhpharm-2026-004996v1.27","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2024-004450"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2026-004996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:20:55Z","timestamp":1782235255000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2026-004996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":27,"alternative-id":["10.1136\/ejhpharm-2026-004996"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2026-004996","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}